Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 3

Pravastatin tedavisi serum neopterin ve CRP düzeyleri ile ölçülen PKG sonrası inflamasyonu baskılamakta yetersiz kalmaktadır

Pravastatin therapy fails to suppress post-PCI inflammatory response measured by serum neopterin and CRP levels

Pages
207–211
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum CRP and neopterin levels were significantly increased after PCI (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Percutaneous coronary intervention (PCI) is known to induce both local and systemic inflammatory states.
📊
Key Findings & Data:Methods: In this randomized prospective study, 93 patients undergoing elective PCI were enrolled.
💡
Conclusion & Impact:Serum CRP and neopterin levels were significantly increased after PCI (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Percutaneous coronary intervention (PCI) is known to induce both local and systemic inflammatory states. In addition to lowering lipid levels, statins exert well-proven anti-inflammatory effects. We investigated the effects of pravastatin on serum C-reactive protein (CRP) and neopterin levels in the short term after elective PCI. Methods: In this randomized prospective study, 93 patients undergoing elective PCI were enrolled. Group 1 (n=30) received pravastatin at a dose of 10 mg/day, Group 2 (n=29) was given 40 mg/day, and Group 3 (n=34) served as the control group and received no lipid-lowering drugs. Blood samples were drawn before and after PCI to measure serum CRP and neopterin levels. Differences among the groups for continuous variables were evaluated by the ANOVA and the Kruskal-Wallis test as appropriate. The Chi-square test was used for comparison of categorical variables. Results: Demographic features and the characteristics of the PCI, including the number of vessels and lesions and the duration and number of inflations, did not differ among groups (p>0.05). Serum CRP and neopterin levels were significantly increased after PCI (p

Özet

Amaç: Perkütan koroner girişim (PKG) sonrası hem lokal, hem de sistemik bir enflamatuvar yanıt meydana gelmektedir. Statinler lipit düşürücü etkilerinin yanında iyi tanımlanmış antienflamatuvar etkilere de sahiptirler. Bu çalışmada pravastatin tedavisinin elektif PKG yapılan hastalarda işlem sonrası serum C-reaktif protein (CRP) ve neopterin düzeyine olan etkisinin değerlendirilmesi amaçlanmıştır.Yöntemler: Bu prospektif, randomize çalışmaya elektif PKG planlanan 93 hasta dahil edildi. Grup 1’e (n=30) pravastatin 10mg/gün, Grup 2’ye (n=29) 40 mg/gün başlandı; Grup 3 (n=34) kontrol grubu alındı ve bu gruba lipit düşürücü tedavi verilmedi. Hastalardan işlem öncesi, işlemden sonra kan örnekleri alınarak serum CRP ve neopterin düzeyleri çalışıldı. Devamlı değişkenlerin gruplar arası karşılaştırılması ANOVA ve Kruskal-Wallis testi ile yapıldı. Devamlı olmayan değişkenler ise Ki-kare testi ile değerlendirildi.Bulgular: Hastaların demografik özellikleri ve PKG ile ilişkili verileri (işlem yapılan damar sayısı, balon şişirme sayısı ve süresi) gruplar arasında benzer idi (p>0.05). Serum CRP ve neopterin düzeylerinde işlemden sonra anlamlı artış saptandı (p

🔖

Cite This Article

KORKMAZ, M. E., MERNEL, S., BOZBAŞ, H., YILDIRIR, A., ÖZİN, B., ATAR, İ., MÜDERİSOĞLU, H., KONAŞ, D., AYDINOĞLU, A. (2022). Pravastatin tedavisi serum neopterin ve CRP düzeyleri ile ölçülen PKG sonrası inflamasyonu baskılamakta yetersiz kalmaktadır. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 3, 207–211. https://ajindex.com/articles/648445

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52
  2. Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D'Amico E, Zweier JL, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997; 29: 1276-83
  3. Serrano CV Jr, Santos ES, Mangione JA, Scheinberg M, Souza JS, Martinez EE, et al. Enhanced inflammatory response following coronary stent implantation in stable angina patients. Int J Cardiol 2007; 118: 69-75
  4. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515-8
  5. Bhatt DL. Inflammation and restenosis: is there a link? Am Heart J 2004; 147: 945-7
  6. Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 2003; 145: 248-53
  7. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-8
  8. Garcia-Moll X, Coccolo F, Cole D, Kaski JC. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000; 35: 956-62
  9. Tanaka T, Nakamura Y, Nasuno A, Mezaki T, Higuchi K, Fukunaga H, et al. Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Circ J 2004; 68: 114-20
  10. Sugioka K, Naruko T, Hozumi T, Nakagawa M, Kitabayashi C, Ikura Y, et al. Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris. Atherosclerosis 2010; 208: 524-30
  11. Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005; 26: 457-63
  12. Berkan O, Katrancıoğlu N, Özker E, Özerdem G, Bakıcı Z, Yılmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: A novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2009; 57: 91-5
  13. Saadeddin SM, Habbab MA. Percutaneous coronary interventio